Pendal Group Ltd - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 233 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
Pendal Group Ltd ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$859,430,000
-18.9%
22,575
-7.4%
0.01%
-26.7%
Q2 2019$1,060,025,000
+20.6%
24,374
+5.5%
0.02%
+25.0%
Q1 2019$879,262,000
-11.5%
23,1020.0%0.01%
-25.0%
Q4 2018$993,848,000
-13.3%
23,102
-1.0%
0.02%0.0%
Q3 2018$1,146,473,000
+53.4%
23,3260.0%0.02%
+60.0%
Q2 2018$747,598,000
+12.4%
23,326
+9.3%
0.01%
+11.1%
Q1 2018$665,084,000
-30.8%
21,351
+1.4%
0.01%
-25.0%
Q4 2017$961,617,000
+23.7%
21,065
+1.7%
0.01%
+20.0%
Q3 2017$777,435,000
+30.3%
20,704
+65.5%
0.01%
+11.1%
Q2 2017$596,632,00012,5080.01%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Doma Perpetual Capital Management LLC 1,000,761$28,631,77213.28%
GAGNON SECURITIES LLC 596,591$17,068,4693.84%
Sio Capital Management, LLC 455,500$13,031,8553.53%
Gagnon Advisors, LLC 133,390$3,816,2882.91%
AlphaCentric Advisors LLC 117,500$3,361,6752.48%
ARDSLEY ADVISORY PARTNERS LP 580,000$16,593,8002.44%
RICE HALL JAMES & ASSOCIATES, LLC 998,625$28,570,6611.71%
Lisanti Capital Growth, LLC 138,830$3,971,9260.96%
Bridge City Capital, LLC 84,856$2,427,7300.82%
Rock Springs Capital Management LP 785,000$22,458,8500.68%
View complete list of PACIRA PHARMACEUTICALS INC shareholders